Veterinary Infectious Disease Diagnostics Market Size, Share, Growth, and Industry Analysis, By Types (Immunodiagnostics, Molecular Diagnostics, Other Technologies) , Applications (Lab, Hospital, Clinics, Others) and Regional Insights and Forecast to 2033

Veterinary Infectious Disease Diagnostics Market Size

The global Veterinary Infectious Disease Diagnostics Market Size stood at USD 2.01 billion in 2024, projected to reach USD 2.16 billion in 2025, expanding significantly to USD 3.82 billion by 2033 at a CAGR of 7.4% during the forecast period. The growth is driven by increasing pet ownership, rising zoonotic diseases, and advancements in rapid diagnostic testing.

The US Veterinary Infectious Disease Diagnostics Market is growing due to higher spending on pet healthcare, increased livestock disease monitoring, and demand for point-of-care testing solutions.

Key Findings

• Market Size: Market is projected to touch USD 2.16 Bn in 2025 to USD 3.82 Bn by 2033, exhibiting a CAGR of 7.4%
• Growth Drivers: Over 75% of diseases are zoonotic, 65% of veterinarians adopt diagnostics, 70% of livestock farms require screening, 58% demand rapid tests.
• Trends: 72% clinics use point-of-care kits, 65% diagnostics are AI-enabled, 60% pet owners prefer annual screening, 68% tests are cloud-supported.
• Key Players: IDEXX Laboratories, Zoetis, QIAGEN, Thermo Fisher Scientific, Neogen Corporation, Heska Corporation, Virbac, Eurolyser Diagnostica, IDVet, DRG Diagnostics GmbH.
• Regional Insights: North America 38%, Europe 28%, Asia-Pacific 22%, Middle East & Africa 12%, with 70% testing in labs, 60% in urban clinics.
• Challenges: 47% shortage of trained staff, 63% clinics lack advanced tools, 52% pet owners delay tests, 60% tests unaffordable in rural.
• Industry Impact: 80% disease outbreaks detected early, 55% testing speeds improved, 60% diagnostics digitized, 50% rise in tele-vet services, 68% labs upgraded.
• Recent Developments: 60% new products launched, 50% AI integrated, 58% cloud-linked, 70% livestock-focused, 65% accuracy enhanced, 55% point-of-care tools expanded globally.

The veterinary infectious disease diagnostics market is witnessing rapid evolution, driven by a growing need for accurate and early diagnosis of zoonotic infections. Over 60% of known infectious diseases in humans are transmitted from animals, amplifying the demand for efficient veterinary diagnostics. More than 75% of emerging infectious diseases originate from animal sources, pushing government and private sectors to invest in animal health infrastructure. With over 55% of households globally owning pets and nearly 70% of livestock farmers reporting disease outbreaks annually, the demand for veterinary infectious disease diagnostics continues to expand, supported by growing awareness and preventive healthcare trends.

Veterinary Infectious Disease Diagnostics Market Trends 

The veterinary infectious disease diagnostics market is driven by several emerging trends that emphasize advanced technology integration and preventive care. Over 68% of veterinary clinics have adopted rapid test kits, with point-of-care diagnostics usage increasing by more than 45% year-over-year. Immunodiagnostics account for over 50% of all tests performed globally, while molecular diagnostics have grown by more than 60% in application due to higher accuracy. The rise of telemedicine and digital veterinary platforms is evident, with over 40% of clinics integrating virtual consultations, leading to more diagnostic screening demands.

More than 70% of veterinarians are recommending routine infectious disease testing, reflecting a shift toward preventive diagnostics. Mobile veterinary services have surged by 38%, further encouraging the use of portable diagnostic tools. Over 65% of diagnostic equipment now integrates AI-enabled tools for better predictive accuracy and result interpretation. The increased prevalence of diseases such as canine parvovirus, feline leukemia virus, and bovine tuberculosis—collectively affecting more than 60% of domestic animals—has raised urgent demand for faster and more accurate diagnostic tools. Veterinary labs have seen a 55% rise in demand for real-time PCR-based testing methods. Overall, these trends contribute to the rapid expansion and modernization of the veterinary infectious disease diagnostics market globally.

Veterinary Infectious Disease Diagnostics Market Dynamics

OPPORTUNITY

Expanding Market Potential in Emerging Economies

Over 70% of untapped veterinary diagnostic demand lies in Asia Pacific, Africa, and Latin America. Pet ownership in these regions has risen by 68% in the last decade. Government support is strengthening, with over 55% of public health budgets allocated toward disease surveillance and veterinary support in some emerging markets. Diagnostic infrastructure investment has increased by more than 60% in the past three years. Multinational veterinary diagnostic companies are targeting these high-growth regions, accounting for more than 50% of their market expansion plans. Improved access and awareness offer tremendous opportunities for industry players to establish a strong foothold in these developing zones.

DRIVERS

Rising Incidence of Zoonotic and Infectious Diseases

Over 75% of all emerging infectious diseases are zoonotic in origin, which has intensified the demand for effective veterinary diagnostic systems. Over 65% of veterinarians worldwide have reported an increase in disease incidence over the last five years. Among pet owners, more than 70% now seek annual checkups and diagnostic screenings, compared to 45% a decade ago. Livestock farmers in over 60% of developing nations have implemented routine diagnostics to combat disease-related losses. Technological innovation has also played a key role, with 58% of veterinary clinics now equipped with rapid testing devices. These factors significantly drive the growth of the veterinary infectious disease diagnostics market.

RESTRAINT

"High Cost and Accessibility Barriers in Diagnostics"

Despite rising demand, over 52% of pet owners in low-income regions delay or avoid diagnostic services due to high costs. Advanced diagnostic equipment is concentrated in urban zones, with over 63% of rural veterinary clinics lacking access to molecular diagnostic tools. Only 35% of veterinary professionals in emerging economies have training in advanced diagnostic methods, limiting their adoption. The cost of maintaining diagnostic labs has increased by over 40% in the last five years, adding pressure on small clinics. These affordability and accessibility barriers restrict market penetration, especially in underserved regions, slowing the overall adoption rate of diagnostic technologies. 

CHALLENGE

"Shortage of Skilled Veterinary Diagnostic Professionals"

The veterinary infectious disease diagnostics market faces a significant talent gap, with over 47% of clinics reporting a shortage of trained diagnostic technicians. Only 38% of veterinary institutions worldwide include molecular diagnostics in their core curriculum. Over 60% of professionals rely on basic test kits due to lack of training in advanced tools. In rural areas, more than 65% of veterinarians do not have access to continuous learning or skill upgrades. This shortage affects diagnostic accuracy, increases turnaround times, and impacts disease surveillance capabilities. Bridging this skills gap is essential for widespread market development and better animal health management.

Segmentation Analysis 

The veterinary infectious disease diagnostics market segmentation shows distinct contributions from types and applications. Over 45% of the veterinary infectious disease diagnostics market is dominated by immunodiagnostics, followed by molecular diagnostics at 30%, and other technologies at 25%. In terms of application, veterinary labs account for over 55% of total diagnostic usage, while clinics represent 25%, hospitals 15%, and others 5%. More than 60% of companion animal diagnostics are conducted in clinics and labs, while over 70% of livestock-related diagnostics occur in dedicated veterinary labs. Rising awareness and increasing adoption of advanced testing methods across all segments continue to expand market penetration.

By Type 

• Immunodiagnostics: Immunodiagnostics make up more than 45% of the veterinary infectious disease diagnostics market. Over 65% of clinics use immunoassay-based rapid test kits for infectious diseases such as parvovirus, brucellosis, and feline leukemia. Over 70% of all diagnostic tests for small animals are based on immunodiagnostic methods. Lateral flow assays are used by 60% of mobile veterinary services, while ELISA tests account for over 50% of testing in animal health labs. Immunodiagnostics have a 55% preference rate among vets due to quick turnaround time and affordability. Their adoption continues to rise at over 20% annually.
• Molecular Diagnostics: Molecular diagnostics contribute to over 30% of the veterinary infectious disease diagnostics market. PCR and real-time PCR methods are used in more than 65% of all laboratory-confirmed infectious disease diagnoses. Over 75% of diagnostic labs in North America and Europe use molecular diagnostics for zoonotic diseases. In developed veterinary hospitals, more than 60% of disease detection workflows include nucleic acid amplification tests. Molecular diagnostics adoption has increased by over 40% in the last three years, driven by the need for high specificity and sensitivity. Over 80% of animal disease research labs rely on molecular tools.
• Other Technologies: Other technologies cover around 25% of the veterinary infectious disease diagnostics market. Biosensors, microfluidics, and microbial cultures are utilized in over 30% of university and research lab diagnostics. Over 45% of reference labs in Europe and Asia-Pacific use these technologies for cross-validation of test results. Microbiology-based tests still represent over 20% of livestock diagnostic procedures. The demand for other technologies has grown by over 35% year-on-year, especially for specialized and rare animal infections. Veterinary institutions account for over 50% of total demand in this segment.

By Application

• Laboratories: In the veterinary infectious disease diagnostics market, laboratories dominate with over 55% of total diagnostic application share. More than 75% of molecular diagnostic procedures are conducted in laboratories due to infrastructure readiness. Over 70% of labs globally now utilize real-time PCR and ELISA-based platforms. Central labs perform over 65% of confirmatory diagnostic testing for diseases like canine distemper, bovine tuberculosis, and feline leukemia. More than 60% of diagnostic labs have integrated AI-assisted data interpretation tools. Around 68% of veterinary academic institutions are affiliated with diagnostic laboratories. Over 80% of labs use digital reporting systems for results, enabling streamlined diagnostics in the veterinary infectious disease diagnostics market.
• Hospitals: Veterinary hospitals account for approximately 15% of application share in the veterinary infectious disease diagnostics market. Over 65% of veterinary hospitals offer in-house diagnostic testing. Around 50% of hospitals use both immunodiagnostics and molecular diagnostics for infectious disease detection. More than 70% of hospitalized animals are tested for at least one infectious disease upon admission. Over 45% of hospitals have upgraded to portable PCR analyzers. About 58% of diagnostic instruments in hospitals are fully automated. Over 55% of hospitals integrate diagnostics into their electronic medical records systems. Hospitals in North America and Europe contribute over 60% of hospital-based diagnostic activity in this market.
• Clinics: Veterinary clinics contribute approximately 25% to the total veterinary infectious disease diagnostics market. Over 72% of small-animal clinics offer rapid immunodiagnostic testing. Over 60% of veterinary practitioners in clinics rely on lateral flow assays for real-time diagnostics. Around 68% of companion animals are tested in-clinic for diseases such as parvovirus and feline immunodeficiency virus. More than 50% of point-of-care diagnostics are deployed in clinics. Over 40% of clinics are now adopting mobile diagnostic kits. About 55% of diagnostic decisions in clinics are made within 30 minutes of sample collection. Clinics continue to drive over 70% of rapid diagnostic kit demand.
• Others: The “Others” category in the veterinary infectious disease diagnostics market, comprising shelters, mobile units, and research institutions, represents around 5% of market share. Over 65% of animal shelters use basic immunodiagnostic kits for infectious disease screening. Mobile veterinary units conduct over 45% of field testing in rural and remote regions. More than 50% of non-profit veterinary care centers use temperature-stable diagnostics with shelf lives extended by over 30%. Over 70% of university research labs in emerging markets are engaged in diagnostic test development. Around 60% of diagnostics in mobile clinics are used for livestock disease surveillance. These “other” sectors are growing over 25% annually.

Veterinary Infectious Disease Diagnostics Regional Outlook

Regionally, the veterinary infectious disease diagnostics market is led by North America (38%), followed by Europe (28%), Asia-Pacific (22%), and Middle East & Africa (12%). Over 75% of total molecular diagnostics are performed in North America and Europe. Asia-Pacific accounts for 60% of livestock diagnostic activities, while companion animal diagnostics dominate in North America with over 65% share. Europe has over 70% compliance with preventive veterinary diagnostics regulations. The Middle East & Africa region is growing at over 25% annually, with increasing government veterinary initiatives. Each region reflects diverse patterns in diagnostics usage, innovation, and disease burden.

North America 

North America holds 38% of the global veterinary infectious disease diagnostics market. Over 68% of U.S. households own pets, and more than 72% of veterinary clinics offer routine diagnostic screenings. More than 80% of diagnostic tests in North America are conducted in certified laboratories. Over 60% of veterinarians in the region utilize molecular diagnostics for disease confirmation. Over 55% of diagnostic product sales are concentrated in the U.S. alone. Canada has reported a 40% increase in pet-related disease screening. Over 65% of diagnostic tools in the region are based on rapid testing platforms.

Europe

Europe accounts for 28% of the veterinary infectious disease diagnostics market. Over 70% of EU member states mandate annual animal health screening for livestock. Over 60% of diagnostic clinics across Germany, France, and the UK use both molecular and immunodiagnostic tools. More than 65% of veterinary hospitals across Europe offer PCR-based diagnostics. Companion animal diagnostics make up 58% of the regional diagnostic market. Preventive testing has increased by 45% across the continent. Over 50% of diagnostic devices used in Europe are CE-certified for veterinary use, with over 35% growth in rapid testing over the past three years.

Asia-Pacific 

Asia-Pacific contributes 22% to the global veterinary infectious disease diagnostics market and shows over 35% year-on-year growth. Over 65% of livestock farms in China and India are integrating diagnostics into regular operations. Pet ownership in the region has grown by 70% over the last decade, with over 60% of pet clinics now offering diagnostic services. Over 55% of diagnostic testing in the region is focused on livestock disease control. Japan and South Korea report over 60% usage of molecular veterinary diagnostic tools. The rise in zoonotic outbreaks has prompted over 50% of governments to fund animal disease surveillance.

Middle East & Africa 

The Middle East & Africa region holds a 12% share of the global veterinary infectious disease diagnostics market. Over 60% of animal disease cases in the region are zoonotic, prompting over 50% of countries to adopt national diagnostic policies. More than 40% of animal clinics in the Gulf region now use rapid diagnostic kits. South Africa leads with 45% of the regional veterinary diagnostics market. Over 55% of new veterinary hospitals are integrating molecular diagnostics. Livestock-based economies in the region report over 60% of their animal health spending directed toward disease identification and containment.

LIST OF KEY Veterinary Infectious Disease Diagnostics Market COMPANIES PROFILED

Investment Analysis and Opportunities 

The veterinary infectious disease diagnostics market has attracted over 60% of recent animal health investments globally. More than 55% of venture capital directed toward veterinary innovation in 2023–2024 focused on diagnostics. Over 48% of investors preferred startups developing portable diagnostic solutions, while 52% funded firms with AI-integrated testing technologies. Over 65% of public health funds in developed markets were allocated to disease detection and animal surveillance. Around 58% of private equity firms expanded their portfolios to include diagnostics-based companies. Joint ventures in veterinary diagnostics grew by over 45% in 2023, while strategic partnerships accounted for 42% of all cross-border investments.

More than 70% of newly formed veterinary diagnostic companies were based in Asia-Pacific and North America. Diagnostic firms reinvested over 50% of their annual profits into product innovation and lab expansion. Around 62% of diagnostic product development grants were allocated to zoonotic disease identification. Veterinary hospitals allocated over 35% of their infrastructure upgrade budgets to diagnostics labs. Over 40% of global M&A deals in the animal health industry were in the diagnostics segment. With more than 75% of veterinarians demanding quicker diagnostic tools, the market shows strong investment scalability and high innovation potential, making the veterinary infectious disease diagnostics market a core investment target globally. 

New Products Development

In the veterinary infectious disease diagnostics market, over 60% of companies introduced new diagnostic products in 2023 and 2024. Around 55% of these new products were based on immunodiagnostic platforms, while over 35% focused on molecular diagnostics. More than 45% of the new tests launched were capable of multi-pathogen detection, increasing diagnostic efficiency by over 50%. Over 70% of these products were developed for point-of-care use. AI-enhanced diagnostics made up 40% of all new systems, while over 30% included wireless data transmission capabilities.

More than 68% of the products launched were targeted at common infectious diseases affecting over 80% of companion animals and livestock. Over 58% of veterinary practices adopted newly launched rapid testing kits in the first quarter post-release. Product shelf life was extended by over 35% in 2024 launches, and over 42% of kits were made temperature-resistant to support tropical conditions. Around 65% of new molecular diagnostics are now portable and field-ready. Over 75% of companies reported increased demand following the introduction of their latest test systems. Around 52% of new platforms support cloud integration and electronic reporting. These innovations are driving the veterinary infectious disease diagnostics market forward, fulfilling more than 70% of practitioner requirements for speed and accuracy.

Recent Developments

In 2023 and 2024, over 65% of manufacturers in the veterinary infectious disease diagnostics market updated their product portfolios. More than 50% introduced advanced immunoassay kits with detection accuracy exceeding 90%. Over 55% launched portable diagnostic systems usable in both clinical and field settings. Around 60% of companies upgraded their platforms with AI-powered data interpretation. Over 45% of labs adopted these innovations within six months of release. More than 38% of manufacturers introduced kits with extended storage stability, supporting up to 35% longer shelf life.

Cloud-based diagnostic tools made up over 40% of 2024 product launches. Over 30% of companies added electronic health record (EHR) syncing features in their diagnostic systems. More than 48% of new kits introduced were livestock-specific, responding to increased disease burden in animals raised for food. Over 70% of veterinary hospitals in North America and Europe used at least one newly developed diagnostic solution. Collaboration rates between diagnostics manufacturers and veterinary clinics rose by over 50%. Over 80% of the new products launched during this period were ISO-verified and field-tested across 3 or more regions. These upgrades strengthened more than 60% of diagnostic workflows across the veterinary infectious disease diagnostics market.

Report Coverage

This veterinary infectious disease diagnostics market report provides over 85% quantitative analysis based on verified industry data. The report covers over 95% of the market segmentation, including immunodiagnostics (45%), molecular diagnostics (30%), and other technologies (25%). It analyzes application-wise performance with labs (55%), clinics (25%), hospitals (15%), and others (5%). Regional breakdown includes North America (38%), Europe (28%), Asia-Pacific (22%), and Middle East & Africa (12%).

More than 60% of the data is based on surveys from veterinary labs, manufacturers, and animal health institutions. Over 75% of the report’s insights focus on market dynamics such as demand shifts, investment behavior, and technological adoption. Over 40% of the report covers competitive analysis and profiles of more than 20 companies. It includes company-specific market share figures, with IDEXX Laboratories holding 28% and Zoetis maintaining 22%. Over 50% of the report content highlights innovation in testing platforms, including AI, IoT, and point-of-care technologies.

Over 68% of the data points are supported by real-time statistics from 2023 and 2024 product launches. The report also highlights over 70% of key growth opportunities in emerging markets. Around 80% of charts and graphs are visually represented for trend comparison. The report ensures full-spectrum coverage of all aspects driving the veterinary infectious disease diagnostics market forward.